Surgery

Lens an option for complicated eyes, astigmatism, monovision candidates.

The company will host Innovation Week from Sept. 21-23, demonstrating new data management innovations across devices, workflow solutions and software applications.

Investigators examine usefulness in refractive surgery evaluations.

Pilot study shows promise of teaching surgeons with technology.

Speed the return to baseline visual acuity—and make your patients happy.

CXL is safe, effective to perform on younger population, study results show.

OD-OS’s teleguidance offering addresses the lack of experts and also benefits teaching in retina laser care.

Early experience with next-generation lens engenders positive perception.

Single-use cataract surgery comes with several safety and quality attributes.

Steven Greenstein, MD, reports on the 10-year postop data from an epi-off corneal collagen cross-linking treatment in keratoconus and ectasia patients.

Sight Sciences reveals real-world data that show the safety, efficacy, and durability of effect of its Omni Surgical System for use in a standalone procedure to reduce IOP and medication burden.

Understanding nuances of reimbursement for novel, sustained-release ophthalmic drugs can help maximize the opportunity for patients and practice.

Substantial weight loss can help patients’ eye health, study results show.

According to the Refractive Surgery Council, patients continue to have a high level of interest in laser vision correction procedures.

Mitch Shultz, MD, speaks on the capabilities of a cloud-based database system to look at energy-fluid metrics, provide surgeons with the capacity to refine procedures and give patients better outcomes.

Mitchell A. Jackson, MD, presents details of a retrospective review of dexamethasone intraocular suspension 9%, including reduced postoperative inflammation.

Colman R. Kraff, MD, shares highlights of a study evaluating the safety and efficacy of the use of the iDesign 2.0 Refractive Studio for the treatment of patients with hyperopia and myopia.

Mark Gallardo, MD, reports 12-month outcomes of iStent inject® combined with cataract surgery in a predominantly Hispanic patient population with mild to moderate open-angle glaucoma (OAG) and comorbid cataract.

Hisaharu Suzuki, MD, PhD, provides insight on how a handpiece maintains the anterior chamber stability even when occlusion occurs, suggesting its usefulness for a safe and efficient surgery.

Kathryn M. Hatch, MD, details how collagen CXL is evolving with the goals of reducing complications and actually improving visual acuity.

Chuck Hess shares an update on Bausch + Lomb's latest developments in surgical technology, as well as how the company has adapted its operations during the pandemic.

Cathleen McCabe, MD, presents results of a retrospective study highlighting the effectiveness of dexamethasone intraocular suspension 9% following cataract surgery.

A new report has found that glaucoma specialists’ procedure of choice has changed as a result of the COVID-19 pandemic.

Physician offers practical advice for the use of systems.

Although minimally invasive procedure gives hope, additional research is required.

Administration has minimal impact on patients’ perception of pain.

ASCRS has issued a statement calling on Aetna to drop a new prior authorization policy it implemented last week that delays cataract surgeries.

Ex vivo experiment identifies potential benefit for supplementary oxygen.

MIGS drainage device offers hope for challenging cases.

Technology enables physicians to provide and receive important information more quickly.